Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Maintenance in Follicular Lymphoma
NCT00430352Phase 4Completed
- Sponsor
- Roche
- Start
- Sep 2006
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 24
01
Overview
A Phase 4 trial of rituximab in follicular lymphoma (FL), sponsored by Roche. Started Sep 2006; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00430352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430352.